This website uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Statement for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time. I accept / More info
For more information on which cookies we use then please refer to our Cookie Policy.
These awards recognize KWM’s leadership in the practice areas of Finance, Compliance, Dispute Resolution, and Intellectual Property, and KWM’s...
A cross-industry initiative on the future economy. We're addressing the rapid pace of change in our markets and the emerging challenges and...
Belt and Road Initiative China's Belt and Road Initiative has attracted global business and media attention as one of the largest and most ambitious...
Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating...
In this article, our partners share their insights on the new Interim Measures along with their impact and the outlook for the Panda bond market.
We advised Prinx Chengshan (Cayman) Holding Limited on its IPO on the Main Board of HKEX.
We advised OPUS Group on its move from the Australian Securities Exchange through a first-of-its-kind scheme of arrangement and HK-Main Board listing.
We represented Qingdao West Coast as offeror under HK laws in the unconditional mandatory cash offer to acquire all shares in Prosper Construction.